García Garayoa E - Search Results

1

Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues.

García Garayoa E, Rüegg D, Bläuenstein P, Zwimpfer M, Khan IU, Maes V, Blanc A, Beck-Sickinger AG, Tourwé DA, Schubiger PA. García Garayoa E, et al. Nucl Med Biol. 2007 Jan;34(1):17-28. doi: 10.1016/j.nucmedbio.2006.10.004. Epub 2006 Nov 28. Nucl Med Biol. 2007. PMID: 17210458

2

Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.

García-Garayoa E, Bläuenstein P, Bruehlmeier M, Blanc A, Iterbeke K, Conrath P, Tourwé D, Schubiger PA. García-Garayoa E, et al. J Nucl Med. 2002 Mar;43(3):374-83. J Nucl Med. 2002. PMID: 11884498 Free article.

3

In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors.

La Bella R, Garcia-Garayoa E, Langer M, Bläuenstein P, Beck-Sickinger AG, Schubiger PA. La Bella R, et al. Among authors: garcia garayoa e. Nucl Med Biol. 2002 Jul;29(5):553-60. doi: 10.1016/s0969-8051(02)00314-1. Nucl Med Biol. 2002. PMID: 12088725

4

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.

García-Garayoa E, Maes V, Bläuenstein P, Blanc A, Hohn A, Tourwé D, Schubiger PA. García-Garayoa E, et al. Nucl Med Biol. 2006 May;33(4):495-503. doi: 10.1016/j.nucmedbio.2006.01.007. Epub 2006 May 2. Nucl Med Biol. 2006. PMID: 16720241

5

A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.

García-Garayoa E, Bläuenstein P, Blanc A, Maes V, Tourwé D, Schubiger PA. García-Garayoa E, et al. Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):37-47. doi: 10.1007/s00259-008-0894-y. Epub 2008 Aug 9. Eur J Nucl Med Mol Imaging. 2009. PMID: 18690434

6

Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.

García Garayoa E, Schweinsberg C, Maes V, Brans L, Bläuenstein P, Tourwe DA, Schibli R, Schubiger PA. García Garayoa E, et al. Bioconjug Chem. 2008 Dec;19(12):2409-16. doi: 10.1021/bc800262m. Bioconjug Chem. 2008. PMID: 18998719

7

Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.

Schweinsberg C, Maes V, Brans L, Bläuenstein P, Tourwé DA, Schubiger PA, Schibli R, García Garayoa E. Schweinsberg C, et al. Among authors: garcia garayoa e. Bioconjug Chem. 2008 Dec;19(12):2432-9. doi: 10.1021/bc800319g. Bioconjug Chem. 2008. PMID: 19053304

8

PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.

Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R. Däpp S, et al. Among authors: garcia garayoa e. Nucl Med Biol. 2011 Oct;38(7):997-1009. doi: 10.1016/j.nucmedbio.2011.02.014. Epub 2011 Apr 21. Nucl Med Biol. 2011. PMID: 21982571

9

In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.

García-Garayoa E, Allemann-Tannahill L, Bläuenstein P, Willmann M, Carrel-Rémy N, Tourwé D, Iterbeke K, Conrath P, Schubiger PA. García-Garayoa E, et al. Nucl Med Biol. 2001 Jan;28(1):75-84. doi: 10.1016/s0969-8051(00)00190-6. Nucl Med Biol. 2001. PMID: 11182567

10

A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.

La Bella R, Garcia-Garayoa E, Bahler M, Bläuenstein P, Schibli R, Conrath P, Tourwé D, Schubiger PA. La Bella R, et al. Among authors: garcia garayoa e. Bioconjug Chem. 2002 May-Jun;13(3):599-604. doi: 10.1021/bc015571a. Bioconjug Chem. 2002. PMID: 12009951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters